vs
Side-by-side financial comparison of Aterian, Inc. (ATER) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $15.1M, roughly 1.3× Aterian, Inc.). Sight Sciences, Inc. runs the higher net margin — -20.4% vs -52.5%, a 32.1% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -13.5%).
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
ATER vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.1M | $20.4M |
| Net Profit | $-7.9M | $-4.2M |
| Gross Margin | 56.1% | 87.3% |
| Operating Margin | -51.1% | -18.0% |
| Net Margin | -52.5% | -20.4% |
| Revenue YoY | -38.5% | 6.9% |
| Net Profit YoY | -512.2% | 64.9% |
| EPS (diluted) | — | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.1M | $20.4M | ||
| Q3 25 | $19.0M | $19.9M | ||
| Q2 25 | $19.5M | $19.6M | ||
| Q1 25 | $15.4M | $17.5M | ||
| Q4 24 | $24.6M | $19.1M | ||
| Q3 24 | $26.2M | $20.2M | ||
| Q2 24 | $28.0M | $21.4M | ||
| Q1 24 | $20.2M | $19.3M |
| Q4 25 | $-7.9M | $-4.2M | ||
| Q3 25 | $-2.3M | $-8.2M | ||
| Q2 25 | $-4.9M | $-11.9M | ||
| Q1 25 | $-3.9M | $-14.2M | ||
| Q4 24 | $-1.3M | $-11.8M | ||
| Q3 24 | $-1.8M | $-11.1M | ||
| Q2 24 | $-3.6M | $-12.3M | ||
| Q1 24 | $-5.2M | $-16.3M |
| Q4 25 | 56.1% | 87.3% | ||
| Q3 25 | 56.1% | 86.4% | ||
| Q2 25 | 54.3% | 84.8% | ||
| Q1 25 | 61.4% | 86.2% | ||
| Q4 24 | 63.4% | 86.8% | ||
| Q3 24 | 60.3% | 83.9% | ||
| Q2 24 | 60.4% | 85.8% | ||
| Q1 24 | 65.1% | 85.5% |
| Q4 25 | -51.1% | -18.0% | ||
| Q3 25 | -10.7% | -39.7% | ||
| Q2 25 | -23.1% | -59.6% | ||
| Q1 25 | -24.1% | -79.2% | ||
| Q4 24 | -6.5% | -62.5% | ||
| Q3 24 | -6.6% | -55.7% | ||
| Q2 24 | -11.5% | -59.2% | ||
| Q1 24 | -26.1% | -76.4% |
| Q4 25 | -52.5% | -20.4% | ||
| Q3 25 | -12.0% | -41.0% | ||
| Q2 25 | -25.0% | -61.0% | ||
| Q1 25 | -25.4% | -80.8% | ||
| Q4 24 | -5.3% | -62.1% | ||
| Q3 24 | -6.8% | -54.9% | ||
| Q2 24 | -13.0% | -57.7% | ||
| Q1 24 | -25.5% | -84.4% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.28 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $-0.25 | ||
| Q1 24 | — | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $15.2M | $63.9M |
| Total Assets | $29.6M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $92.0M | ||
| Q3 25 | $7.6M | $92.4M | ||
| Q2 25 | $10.5M | $101.5M | ||
| Q1 25 | $14.3M | $108.8M | ||
| Q4 24 | $18.0M | $120.4M | ||
| Q3 24 | $16.1M | $118.6M | ||
| Q2 24 | $20.3M | $118.2M | ||
| Q1 24 | $17.5M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $15.2M | $63.9M | ||
| Q3 25 | $22.6M | $64.3M | ||
| Q2 25 | $24.3M | $70.0M | ||
| Q1 25 | $27.0M | $77.6M | ||
| Q4 24 | $30.0M | $87.5M | ||
| Q3 24 | $30.6M | $95.0M | ||
| Q2 24 | $30.9M | $101.6M | ||
| Q1 24 | $33.0M | $109.2M |
| Q4 25 | $29.6M | $115.3M | ||
| Q3 25 | $40.1M | $116.3M | ||
| Q2 25 | $45.4M | $122.0M | ||
| Q1 25 | $49.8M | $129.7M | ||
| Q4 24 | $49.5M | $142.8M | ||
| Q3 24 | $52.1M | $143.6M | ||
| Q2 24 | $59.9M | $149.7M | ||
| Q1 24 | $55.7M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-1.8M |
| Free Cash FlowOCF − Capex | $-1.0M | $-2.0M |
| FCF MarginFCF / Revenue | -6.9% | -9.7% |
| Capex IntensityCapex / Revenue | 0.0% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.0M | $-1.8M | ||
| Q3 25 | $-1.6M | $-8.7M | ||
| Q2 25 | $-4.4M | $-7.5M | ||
| Q1 25 | $-3.9M | $-11.6M | ||
| Q4 24 | $-9.0K | $-3.5M | ||
| Q3 24 | $-722.0K | $362.0K | ||
| Q2 24 | $2.9M | $-9.5M | ||
| Q1 24 | $-6.0K | $-9.8M |
| Q4 25 | $-1.0M | $-2.0M | ||
| Q3 25 | $-1.6M | $-8.9M | ||
| Q2 25 | $-4.4M | $-7.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | — | $311.0K | ||
| Q2 24 | $2.9M | $-9.5M | ||
| Q1 24 | $-42.0K | $-9.9M |
| Q4 25 | -6.9% | -9.7% | ||
| Q3 25 | -8.4% | -44.7% | ||
| Q2 25 | -22.7% | -39.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -18.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | 10.3% | -44.7% | ||
| Q1 24 | -0.2% | -51.4% |
| Q4 25 | 0.0% | 0.8% | ||
| Q3 25 | 0.2% | 0.9% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.0% | 0.7% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.2% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
